Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	RMDResMed	GEHCGE HealthCare	DXCMDexcom
Snapshot
Price	$213.94	$71.20	$83.47
Market cap	$30.41B	$29.82B	$27.49B
Valuation
P/E	20.4x	17.4x	34.9x
Forward P/E	17.5x	19.8x	25x
Growth
Revenue growth	10.3%	6.0%	16.1%
EPS growth	16.5%	-12.3%	77.5%
Profitability
Net margin	27.4%	9.1%	19.3%
ROE	24.4%	18.8%	33.8%
Balance sheet & cash
Debt / equity	0.11x	0.97x	0.47x
Free cash flow yield	3.8%	7.7%	1.8%
Dividend yield	1.2%	0.2%	—
Verdict
Investment rating	Strong· 75	Neutral· 51	Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	RMDtoday $214	GEHCtoday $71	DXCMtoday $83
2027	$186.88 – $274.09+28% CAGR	$54.47 – $79.89+12% CAGR	$111.09 – $162.93+95% CAGR
2028	$217.66 – $319.24+22% CAGR	$55.56 – $81.48+7% CAGR	$197.13 – $289.12+86% CAGR
2029	$253.51 – $371.81+20% CAGR	$56.67 – $83.11+5% CAGR	$349.80 – $513.04+83% CAGR
2030	$295.26 – $433.05+19% CAGR	$57.80 – $84.78+4% CAGR	$620.72 – $910.39+82% CAGR
2031	$343.89 – $504.38+19% CAGR	$58.96 – $86.47+4% CAGR	$1,101.47 – $1,615.49+81% CAGR
5-yr CAGR	10.0% – 18.7%	-3.7% – 4.0%	67.5% – 80.9%